High Levels of Well-Being Protect Against Cardiovascular Disease
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 20, 2024 -- High levels of well-being may protect against the risks for cardiovascular diseases (CVDs), according to a study published online Sept. 18 in the Journal of the American Heart Association.
Jinghui Zhong, from the University of Science and Technology of China in Hefei, and colleagues used data from 121,317 participants in the U.K. Biobank to assess the relationship of a well-being index using general happiness and satisfaction with family, friendships, health, and finance situations with four major CVDs.
The researchers found that higher well-being was associated with a significantly reduced risk for various CVDs. Four distinct well-being groups were identified in latent class analysis (low, variable, moderate-to-high, and high satisfaction), with higher satisfaction levels generally associated with a lower risk for CVDs. There were potential causal relationships between well-being and a reduced risk for CVDs using Mendelian randomization. There were associations between greater well-being and healthier behaviors and lower levels of inflammatory markers. These lifestyle and inflammatory markers partially mediated the relationship between well-being and CVDs.
"Enhancing well-being could lead to a reduced incidence of cardiovascular and cerebrovascular diseases, warranting focused prevention trials. Additionally, exploring the biological indicators bridging well-being and CVD may offer fresh perspectives on its pathogenesis," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-21 12:00
Read more
- Malaria Developing Resistance to Drug That Saves Children's Lives
- Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death
- Clinical Practice Guidelines Updated for Primary Prevention of Stroke
- Greater Fine Particulate Matter Linked to Increased Odds of Eczema
- Optimal Timing of Maternal RSV Vaccine Determined to Be at Least Five Weeks Before Delivery
- Half of U.S. Teens Stare at Screens More Than 4 Hours Per Day
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions